These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Selective inhibitor of proteasome's caspase-like sites sensitizes cells to specific inhibition of chymotrypsin-like sites. Britton M; Lucas MM; Downey SL; Screen M; Pletnev AA; Verdoes M; Tokhunts RA; Amir O; Goddard AL; Pelphrey PM; Wright DL; Overkleeft HS; Kisselev AF Chem Biol; 2009 Dec; 16(12):1278-89. PubMed ID: 20064438 [TBL] [Abstract][Full Text] [Related]
4. A cell-permeable inhibitor and activity-based probe for the caspase-like activity of the proteasome. van Swieten PF; Samuel E; Hernández RO; van den Nieuwendijk AM; Leeuwenburgh MA; van der Marel GA; Kessler BM; Overkleeft HS; Kisselev AF Bioorg Med Chem Lett; 2007 Jun; 17(12):3402-5. PubMed ID: 17442566 [TBL] [Abstract][Full Text] [Related]
5. C-terminal constrained phenylalanine as a pharmacophoric unit in peptide-based proteasome inhibitors. Baldisserotto A; Marastoni M; Lazzari I; Trapella C; Gavioli R; Tomatis R Eur J Med Chem; 2008 Jul; 43(7):1403-11. PubMed ID: 17996987 [TBL] [Abstract][Full Text] [Related]
6. Extended peptide-based inhibitors efficiently target the proteasome and reveal overlapping specificities of the catalytic beta-subunits. Kessler BM; Tortorella D; Altun M; Kisselev AF; Fiebiger E; Hekking BG; Ploegh HL; Overkleeft HS Chem Biol; 2001 Sep; 8(9):913-29. PubMed ID: 11564559 [TBL] [Abstract][Full Text] [Related]
7. Towards subunit-specific proteasome inhibitors: synthesis and evaluation of peptide alpha',beta'-epoxyketones. Elofsson M; Splittgerber U; Myung J; Mohan R; Crews CM Chem Biol; 1999 Nov; 6(11):811-22. PubMed ID: 10574782 [TBL] [Abstract][Full Text] [Related]
8. New 26S proteasome inhibitors with high selectivity for chymotrypsin-like activity and p53-dependent cytotoxicity. Neilsen PM; Pehere AD; Pishas KI; Callen DF; Abell AD ACS Chem Biol; 2013 Feb; 8(2):353-9. PubMed ID: 23190346 [TBL] [Abstract][Full Text] [Related]
9. Tripeptide analogues of MG132 as protease inhibitors. Pehere AD; Nguyen S; Garlick SK; Wilson DW; Hudson I; Sykes MJ; Morton JD; Abell AD Bioorg Med Chem; 2019 Jan; 27(2):436-441. PubMed ID: 30581047 [TBL] [Abstract][Full Text] [Related]
10. Development of novel peptidomimetics containing a vinyl sulfone moiety as proteasome inhibitors. Ettari R; Bonaccorso C; Micale N; Heindl C; Schirmeister T; Calabrò ML; Grasso S; Zappalà M ChemMedChem; 2011 Jul; 6(7):1228-37. PubMed ID: 21506279 [TBL] [Abstract][Full Text] [Related]
12. New betulinic acid derivatives as potent proteasome inhibitors. Qian K; Kim SY; Hung HY; Huang L; Chen CH; Lee KH Bioorg Med Chem Lett; 2011 Oct; 21(19):5944-7. PubMed ID: 21856154 [TBL] [Abstract][Full Text] [Related]
13. The Proteasome as a Drug Target in the Metazoan Pathogen, Bibo-Verdugo B; Wang SC; Almaliti J; Ta AP; Jiang Z; Wong DA; Lietz CB; Suzuki BM; El-Sakkary N; Hook V; Salvesen GS; Gerwick WH; Caffrey CR; O'Donoghue AJ ACS Infect Dis; 2019 Oct; 5(10):1802-1812. PubMed ID: 31355632 [TBL] [Abstract][Full Text] [Related]
14. Carfilzomib can induce tumor cell death through selective inhibition of the chymotrypsin-like activity of the proteasome. Parlati F; Lee SJ; Aujay M; Suzuki E; Levitsky K; Lorens JB; Micklem DR; Ruurs P; Sylvain C; Lu Y; Shenk KD; Bennett MK Blood; 2009 Oct; 114(16):3439-47. PubMed ID: 19671918 [TBL] [Abstract][Full Text] [Related]
15. Phenoxypropanolamine derivatives as selective inhibitors of the 20S proteasome β1 and β5 subunits. Hovhannisyan AA; Pham TH; Bouvier D; Tan X; Touhar S; Mkryan GG; Dallakyan AM; El Amri C; Melikyan GS; Reboud-Ravaux M; Bouvier-Durand M Bioorg Med Chem Lett; 2017 Dec; 27(23):5172-5178. PubMed ID: 29113763 [TBL] [Abstract][Full Text] [Related]
16. P'-extended alpha-ketoamide inhibitors of proteasome. Chatterjee S; Dunn D; Mallya S; Ator MA Bioorg Med Chem Lett; 1999 Sep; 9(17):2603-6. PubMed ID: 10498217 [TBL] [Abstract][Full Text] [Related]
17. Constitutively expressed catalytic proteasomal subunits are up-regulated during neuronal differentiation and required for axon initiation, elongation and maintenance. Klimaschewski L; Hausott B; Ingorokva S; Pfaller K J Neurochem; 2006 Mar; 96(6):1708-17. PubMed ID: 16539686 [TBL] [Abstract][Full Text] [Related]
18. N-[2,2-dimethyl-3-(N-(4-cyanobenzoyl)amino)nonanoyl]-L-phenylalanine ethyl ester as a stable ester-type inhibitor of chymotrypsin-like serine proteases: structural requirements for potent inhibition of alpha-chymotrypsin. Iijima K; Katada J; Yasuda E; Uno I; Hayashi Y J Med Chem; 1999 Jan; 42(2):312-23. PubMed ID: 9925737 [TBL] [Abstract][Full Text] [Related]
19. Methylation of green tea polyphenols affects their binding to and inhibitory poses of the proteasome beta5 subunit. Daniel KG; Landis-Piwowar KR; Chen D; Wan SB; Chan TH; Dou QP Int J Mol Med; 2006 Oct; 18(4):625-32. PubMed ID: 16964415 [TBL] [Abstract][Full Text] [Related]
20. Synthetic inhibitors of the multicatalytic proteinase complex (proteasome). Wilk S; Figueiredo-Pereira ME Enzyme Protein; 1993; 47(4-6):306-13. PubMed ID: 7697128 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]